> Skip to content
FEATURED:
  • The Evolution of Race in Admissions
Sign In
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Find a Job
    • Post a Job
Sign In
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Find a Job
    • Post a Job
  • News
  • Advice
  • The Review
  • Data
  • Current Issue
  • Virtual Events
  • Store
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
    • Featured Products
    • Reports
    • Data
    • Collections
    • Back Issues
  • Jobs
    • Find a Job
    • Post a Job
    • Find a Job
    • Post a Job
Sign In
ADVERTISEMENT
News
  • Twitter
  • LinkedIn
  • Show more sharing options
Share
  • Twitter
  • LinkedIn
  • Facebook
  • Email
  • Copy Link URLCopied!
  • Print

Private Canadian Research Laboratory Sold to French

By  Mark Gerson
January 3, 1990

Connaught Biosciences Inc., one of Canada’s most respected private laboratories and its leading producer of vaccines, has been taken over by a French company. The action was criticized by many Canadian scientists and politicians.

The federal Cabinet cleared the way for Connaught’s purchase by France’s Institut Merieux after Investment Canada, an agency of the Canadian government, said the change would provide “net benefits” to Canada.

Investment Canada has the power to block foreign purchases of Canadian businesses worth more than $25-million (Canadian).

We’re sorry. Something went wrong.

We are unable to fully display the content of this page.

The most likely cause of this is a content blocker on your computer or network. Please make sure your computer, VPN, or network allows javascript and allows content to be delivered from c950.chronicle.com and chronicle.blueconic.net.

Once javascript and access to those URLs are allowed, please refresh this page. You may then be asked to log in, create an account if you don't already have one, or subscribe.

If you continue to experience issues, contact us at 202-466-1032 or help@chronicle.com

Connaught Biosciences Inc., one of Canada’s most respected private laboratories and its leading producer of vaccines, has been taken over by a French company. The action was criticized by many Canadian scientists and politicians.

The federal Cabinet cleared the way for Connaught’s purchase by France’s Institut Merieux after Investment Canada, an agency of the Canadian government, said the change would provide “net benefits” to Canada.

Investment Canada has the power to block foreign purchases of Canadian businesses worth more than $25-million (Canadian).

The University of Toronto, owner of Connaught until 1972, began legal action last July to block the sale. However, the university dropped its objections in November when Merieux agreed to finance “leading-edge” research worth $15-million at Toronto and other Canadian universities over the next decade.

Merieux also has agreed to spend $160-million on research and development in Canada by 1994, including $39-million on basic research; to build a biotechnology center in Toronto; and to retain Connaught’s existing Canadian headquarters, facilities, and employment levels.

ADVERTISEMENT

In Quebec, meanwhile, the provincial government has fired the board of directors of the University of Quebec’s Armand Frappier Institute for refusing to complete the previously negotiated sale of the institute’s vaccine-production division to a Quebec company.

The institute had put the money-losing division on the market a year ago.

Ironically, it was a proposal to sell the division to Connaught when the Toronto laboratory was still Canadian-owned that prompted the Quebec government to help negotiate a deal to retain control of the Armand Frappier division in Quebec.

We welcome your thoughts and questions about this article. Please email the editors or submit a letter for publication.
ADVERTISEMENT
ADVERTISEMENT
  • Explore
    • Get Newsletters
    • Letters
    • Free Reports and Guides
    • Blogs
    • Virtual Events
    • Chronicle Store
    • Find a Job
    Explore
    • Get Newsletters
    • Letters
    • Free Reports and Guides
    • Blogs
    • Virtual Events
    • Chronicle Store
    • Find a Job
  • The Chronicle
    • About Us
    • DEI Commitment Statement
    • Write for Us
    • Talk to Us
    • Work at The Chronicle
    • User Agreement
    • Privacy Policy
    • California Privacy Policy
    • Site Map
    • Accessibility Statement
    The Chronicle
    • About Us
    • DEI Commitment Statement
    • Write for Us
    • Talk to Us
    • Work at The Chronicle
    • User Agreement
    • Privacy Policy
    • California Privacy Policy
    • Site Map
    • Accessibility Statement
  • Customer Assistance
    • Contact Us
    • Advertise With Us
    • Post a Job
    • Advertising Terms and Conditions
    • Reprints & Permissions
    • Do Not Sell My Personal Information
    Customer Assistance
    • Contact Us
    • Advertise With Us
    • Post a Job
    • Advertising Terms and Conditions
    • Reprints & Permissions
    • Do Not Sell My Personal Information
  • Subscribe
    • Individual Subscriptions
    • Institutional Subscriptions
    • Subscription & Account FAQ
    • Manage Newsletters
    • Manage Your Account
    Subscribe
    • Individual Subscriptions
    • Institutional Subscriptions
    • Subscription & Account FAQ
    • Manage Newsletters
    • Manage Your Account
1255 23rd Street, N.W. Washington, D.C. 20037
© 2023 The Chronicle of Higher Education
  • twitter
  • instagram
  • youtube
  • facebook
  • linkedin